BackConnect Biopharma Holdings Overview
Connect Biopharma Holdings Ltd - ADR

Connect Biopharma Holdings Target Price

Where could CNTB trade next? Consensus target price: $6.4.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.54

Average Target Price

$6.40152% upside

5 analysts in the last 4 months

High: $8 | Low: $4

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-09Oppenheimer$8215% upsideOpen
2026-06-26Piper Sandler$7175.6% upsideOpen
2026-06-18H.C. WainwrightBrandon Folkes$7175.6% upsideOpen
2026-05-26Canaccord GenuityEdward Nash$6136.2% upsideOpen
2026-05-21Cantor FitzgeraldOlivia Brayer$457.5% upsideOpen
2025-12-01Lake StreetThomas Flaten$9254.3% upsideOpen
2022-05-05Piper SandlerJoseph Catanzaro$1.540.9% downsideOpen

Connect Biopharma Holdings (CNTB) FAQ

As of the most recent data, CNTB shows a target price of $6.4. Scroll down for historical charts and peer comparison views.

If Connect Biopharma Holdings moved to the average analyst target of $6.4, shares would be roughly 152.0% higher than $2.54. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Connect Biopharma Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Connect Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $6.4) with ownership activity and broader fundamentals.

Connect Biopharma Holdings's target price is $6.4; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.